Neumora’s schizophrenia drug hit with clinical hold
Shares of Neumora Therapeutics fell Monday after the company disclosed a small clinical trial testing one of its experimental medicines for schizophrenia has been halted by the Food and Drug Administration. According to Neumora, the hold comes on the heels of new data from animal testing that found rabbits convulsed after receiving the medicine, which…
